We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

126 hedge funds and large institutions have $381M invested in ImmunityBio in 2021 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more capital invested

Capital invested by funds: $155M → $381M (+$226M)

110% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 20

21% more funds holding

Funds holding: 104 → 126 (+22)

19% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 32

6.55% less ownership

Funds ownership: 10.75% → 4.19% (-6.6%)

53% less call options, than puts

Call options by funds: $24M | Put options by funds: $50.7M

Holders
126
Holders Change
+22
Holders Change %
+21.15%
% of All Funds
2.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
38
Reduced
32
Closed
20
Calls
$24M
Puts
$50.7M
Net Calls
-$26.7M
Net Calls Change
-$12.6M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$43.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$13.8M
3
Rafferty Asset Management
Rafferty Asset Management
New York
+$12.1M
4
HP
Harbourvest Partners
Massachusetts
+$9M
5
BlackRock
BlackRock
New York
+$6.49M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$8.63M
2
Group One Trading
Group One Trading
Illinois
-$2.39M
3
N
Nuveen
North Carolina
-$1.5M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$1.38M
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$1.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
26
Swiss National Bank
Switzerland
$1.77M +$33.7K +1,300 +2%
Millennium Management
27
Millennium Management
New York
$1.76M +$1.93M +74,342 New
CCA
28
Clearwater Capital Advisors
Illinois
$1.71M +$984K +37,971 +111%
LPL Financial
29
LPL Financial
California
$1.52M +$1.66M +64,205 New
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$1.52M -$162K -6,260 -9%
Blackstone Inc
31
Blackstone Inc
New York
$1.38M +$1.5M +58,009 New
UBS Group
32
UBS Group
Switzerland
$1.33M +$1.32M +50,858 +986%
Wells Fargo
33
Wells Fargo
California
$1.22M +$179K +6,903 +15%
PAMU
34
Pictet Asset Management (UK)
United Kingdom
$1.14M +$1.25M +48,195 New
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$1.13M -$4.46K -172 -0.4%
AllianceBernstein
36
AllianceBernstein
Tennessee
$1.09M -$59.6K -2,300 -5%
Mitsubishi UFJ Asset Management
37
Mitsubishi UFJ Asset Management
Japan
$1.04M +$385K +14,843 +51%
Jane Street
38
Jane Street
New York
$1.01M -$785K -30,265 -42%
State of Wisconsin Investment Board
39
State of Wisconsin Investment Board
Wisconsin
$1.01M +$41.5K +1,600 +4%
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$983K +$110K +4,238 +11%
WPA
41
Winning Points Advisors
Florida
$974K – – –
WAS
42
Wealth Advisory Solutions
Indiana
$974K +$1.04M +40,000 New
Simplex Trading
43
Simplex Trading
Illinois
$936K -$740K -28,528 -42%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$900K -$63.2K -2,437 -6%
Creative Planning
45
Creative Planning
Kansas
$898K -$83.2K -3,208 -8%
EMG
46
ETF Managers Group
New Jersey
$894K -$394K -15,185 -29%
Wolverine Trading
47
Wolverine Trading
Illinois
$870K -$17.3K -666 -2%
Bank of America
48
Bank of America
North Carolina
$860K +$446K +17,190 +90%
Victory Capital Management
49
Victory Capital Management
Texas
$846K +$106K +4,098 +13%
ECM
50
ExodusPoint Capital Management
New York
$838K +$915K +35,312 New
1
2
3 4 5

IBRX Hedge Fund Activity: Q1 2021 in Review

126 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q1 2021, worth a combined $381M — up 145% from $155M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new IBRX positions and 20 closed out — a net gain of 22 holders — while 38 added to existing stakes and 32 trimmed.

The largest buyer was State Street, adding an estimated $43.2M. The largest seller was Invesco, cutting an estimated $8.63M.

  • 126 institutional investors held ImmunityBio (IBRX) as of Q1 2021, up from 104 in Q4 2020.
  • Funds reported $381M of ImmunityBio stock for Q1 2021, up 145% quarter-over-quarter.
  • 42 funds opened new ImmunityBio positions in Q1 2021 and 20 closed out, a net change of +22 holders.
  • The largest ImmunityBio buyer in Q1 2021 was State Street, an estimated $43.2M added.
  • The largest ImmunityBio seller in Q1 2021 was Invesco, an estimated $8.63M sold.

Based on aggregated 13F filings for Q1 2021.